{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:57:58Z","timestamp":1793408278264,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232142"],"award-info":[{"award-number":["7232142"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202612"],"award-info":[{"award-number":["82202612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.gendis.2025.101919","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:25:08Z","timestamp":1762464308000},"page":"101919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential oncogenic role of occult hepatitis B virus pre-S mutations: Activation of Akt\/mTOR\/Cyclin D1 signaling drives cell cycle dysregulation and proliferation in hepatocellular carcinogenesis"],"prefix":"10.1016","volume":"13","author":[{"given":"Huizhen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-7891","authenticated-orcid":false,"given":"Lunan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gendis.2025.101919_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: an opportunity to transform care","volume":"9","author":"Easterbrook","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101919_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101919_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/pathogens13080662","article-title":"Occult hepatitis B virus infection in hepatic diseases and its significance for the WHO's elimination plan of viral hepatitis","volume":"13","author":"Bucio-Ortiz","year":"2024","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.gendis.2025.101919_bib5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","article-title":"Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance","volume":"73","author":"Mak","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101919_bib6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.gendis.2025.101919_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cgh.2019.06.029","article-title":"Among patients with undetectable hepatitis B surface antigen and hepatocellular carcinoma, a high proportion has integration of HBV DNA into hepatocyte DNA and no cirrhosis","volume":"18","author":"Wong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101919_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.24551","article-title":"Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma","volume":"54","author":"Wong","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gendis.2025.101919_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2009.02.013","article-title":"Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China","volume":"58","author":"Fang","year":"2009","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.gendis.2025.101919_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2201","article-title":"Hepatitis B virus pre-S region: clinical implications and applications","volume":"31","author":"Sun","year":"2021","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101919_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/v14020428","article-title":"Approaches for detection of hepatitis B virus pre-S gene deletions and pre-S deleted proteins and their application in prediction of higher risk of hepatocellular carcinoma development and recurrence","volume":"14","author":"Lin","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.gendis.2025.101919_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/v13050862","article-title":"Hepatitis B virus pre-S gene deletions and pre-S deleted proteins: clinical and molecular implications in hepatocellular carcinoma","volume":"13","author":"Lin","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.gendis.2025.101919_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.31789","article-title":"Clinical implications of HBV PreS\/S mutations and the effects of PreS2 deletion on mitochondria, liver fibrosis, and cancer development","volume":"74","author":"Liang","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2025.101919_bib14","doi-asserted-by":"crossref","first-page":"105448","DOI":"10.1016\/j.antiviral.2022.105448","article-title":"Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2\/S promoter activity","volume":"208","author":"Sun","year":"2022","journal-title":"Antiviral Res"},{"issue":"14","key":"10.1016\/j.gendis.2025.101919_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00660-21","article-title":"Lost small envelope protein expression from naturally occurring PreS1 deletion mutants of hepatitis B virus is often accompanied by increased HBx and core protein expression as well as genome replication","volume":"95","author":"Fu","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib16","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1038\/s41467-018-05782-5","article-title":"Intracellular interleukin-32\u03b3 mediates antiviral activity of cytokines against hepatitis B virus","volume":"9","author":"Kim","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2025.101919_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.840825","article-title":"The serious challenge of occult hepatitis B virus infection-related hepatocellular carcinoma in China","volume":"13","author":"Xia","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gendis.2025.101919_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251320492","article-title":"Molecular mechanisms and therapeutic targets of hepatitis B virus pre-S mutant-associated hepatocellular carcinoma tumorigenesis","volume":"32","author":"Jeng","year":"2025","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12885-019-5916-6","article-title":"HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models","volume":"19","author":"Torresi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gendis.2025.101919_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2019.09.006","article-title":"LncRNA H19\/microRNA-675\/PPAR\u03b1 axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt\/mTOR signalling","volume":"116","author":"Liu","year":"2019","journal-title":"Mol Immunol"},{"issue":"24","key":"10.1016\/j.gendis.2025.101919_bib22","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/0008-5472.CAN-11-2260","article-title":"Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src\/PI3K\/Akt pathway","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.gendis.2025.101919_bib23","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.22889","article-title":"Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis","volume":"49","author":"Yang","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib25","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1038\/s41467-024-50063-z","article-title":"Combined inhibition of KRAS(G12C) and mTORC1 kinase is synergistic in non-small cell lung cancer","volume":"15","author":"Kitai","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gendis.2025.101919_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41419-021-03661-4","article-title":"MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.gendis.2025.101919_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/15548627.2019.1569918","article-title":"Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis","volume":"15","author":"Wu","year":"2019","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.29781","article-title":"Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system","volume":"68","author":"Wu","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.gendis.2025.101919_bib29","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.3390\/ijms23105376","article-title":"The serum hepatitis B virus large surface protein as high-risk recurrence biomarker for hepatoma after curative surgery","volume":"23","author":"Tsai","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101919_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/v13061124","article-title":"Envelope proteins of hepatitis B virus: molecular biology and involvement in carcinogenesis","volume":"13","author":"Inoue","year":"2021","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.gendis.2025.101919_bib31","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/cells9092052","article-title":"Association of the hepatitis B virus large surface protein with viral infectivity and endoplasmic reticulum stress-mediated liver carcinogenesis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.gendis.2025.101919_bib32","doi-asserted-by":"crossref","first-page":"22256","DOI":"10.18632\/aging.203531","article-title":"Nucleotide variants in the hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"issue":"6","key":"10.1016\/j.gendis.2025.101919_bib33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/v14061346","article-title":"Association of increased programmed death ligand 1 expression and regulatory T cells infiltration with higher hepatocellular carcinoma recurrence in patients with hepatitis B virus pre-S2 mutant after curative surgical resection","volume":"14","author":"Jeng","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.gendis.2025.101919_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/v12090945","article-title":"Hepatitis B virus pre-S mutants as biomarkers and targets for the development and recurrence of hepatocellular carcinoma","volume":"12","author":"Teng","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.gendis.2025.101919_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/JHC.S282818","article-title":"Increased expression of programmed death ligand 1 in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant","volume":"7","author":"Teng","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"issue":"17","key":"10.1016\/j.gendis.2025.101919_bib36","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/cncr.34815","article-title":"Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection","volume":"129","author":"Jeng","year":"2023","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.gendis.2025.101919_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028977","article-title":"Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells","volume":"6","author":"Hung","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2025.101919_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29348","article-title":"Characterization of integrated hepatitis B virus DNA harboring pre-S mutations in hepatocellular carcinoma patients with ground glass hepatocytes","volume":"96","author":"Su","year":"2024","journal-title":"J Med Virol"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:18:29Z","timestamp":1785881909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2352304225004088"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101919","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential oncogenic role of occult hepatitis B virus pre-S mutations: Activation of Akt\/mTOR\/Cyclin D1 signaling drives cell cycle dysregulation and proliferation in hepatocellular carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101919"}}